Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

January

15
2025

Sensus Healthcare Reports First Quarter 2025 Financial Results

21 SRT systems shipped during the quarter; revenues of $8.3…

January

06
2025

Sensus Healthcare to Showcase Commercial and Late-Stage Products at the American Academy of Dermatology Annual Meeting

Full line of SRT products along with innovative pre-commercial products…

January

04
2025

Sensus Healthcare Announces Publication of Study at Tri Service Military Hospital in Taiwan Demonstrating Efficacy of SRT-100® in Preventing Keloid Recurrence

BOCA RATON, Fla. – Sensus Healthcare, Inc. (Nasdaq: SRTS), a…

January

28
2025

The Evolution of Skin Cancer Treatment: How SRT-100 Vision is Changing the Game in Non-Invasive Skin Cancer Treatment

Skin cancer, particularly non-melanoma skin cancer (NMSC), is one of…

January

28
2025

Introducing the Fair Deal Agreement: Revolutionizing Dermatology Practices with Sensus Healthcare

At Sensus Healthcare, we are committed to advancing patient care…